Additionally, ALK::STRN and ALK::PLEKHA7 gene fusions have been described in tumors mimicking metanephric adenoma, corroborating the notion that gene fusion partners might impact morphology and even clinical outcomes [32, 35]. This evidence concerns the gene PLEKHA7 and metanephric adenoma.